Oppenheimer & Co’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $372K | Sell |
7,521
-6,418
| -46% | -$326K | ﹤0.01% | 1389 |
|
|
2026
Q1 | $744K | Buy |
13,939
+1,256
| +10% | +$73.8K | 0.01% | 1012 |
|
|
2025
Q4 | $788K | Sell |
12,683
-431
| -3% | -$26.6K | 0.01% | 894 |
|
|
2025
Q3 | $788K | Sell |
13,114
-1,585
| -11% | -$97K | 0.01% | 1007 |
|
|
2025
Q2 | $921K | Buy |
14,699
+515
| +4% | +$30.9K | 0.01% | 896 |
|
|
2025
Q1 | $854K | Buy |
14,184
+1,447
| +11% | +$89.9K | 0.01% | 874 |
|
|
2024
Q4 | $743K | Sell |
12,737
-1,804
| -12% | -$107K | 0.01% | 919 |
|
|
2024
Q3 | $861K | Buy |
14,541
+1,682
| +13% | +$96.1K | 0.01% | 845 |
|
|
2024
Q2 | $721K | Sell |
12,859
-1,493
| -10% | -$83.6K | 0.01% | 882 |
|
|
2024
Q1 | $841K | Sell |
14,352
-37,064
| -72% | -$2.09M | 0.01% | 803 |
|
|
2023
Q4 | $2.77M | Sell |
51,416
-1,301
| -2% | -$63.6K | 0.05% | 411 |
|
|
2023
Q3 | $2.56M | Buy |
52,717
+34,315
| +186% | +$1.82M | 0.05% | 390 |
|
|
2023
Q2 | $1.04M | Buy |
18,402
+540
| +3% | +$29.7K | 0.02% | 689 |
|
|
2023
Q1 | $964K | Sell |
17,862
-8,191
| -31% | -$436K | 0.02% | 712 |
|
|
2022
Q4 | $1.37M | Buy |
26,053
+9,305
| +56% | +$472K | 0.03% | 551 |
|
|
2022
Q3 | $790K | Sell |
16,748
-1,781
| -10% | -$92.4K | 0.02% | 729 |
|
|
2022
Q2 | $935K | Sell |
18,529
-485
| -3% | -$26.4K | 0.02% | 711 |
|
|
2022
Q1 | $1.16M | Sell |
19,014
-5,491
| -22% | -$327K | 0.02% | 688 |
|
|
2021
Q4 | $1.61M | Buy |
24,505
+2,808
| +13% | +$180K | 0.03% | 587 |
|
|
2021
Q3 | $1.36M | Buy |
21,697
+4,519
| +26% | +$288K | 0.03% | 636 |
|
|
2021
Q2 | $1.03M | Buy |
17,178
+2,022
| +13% | +$117K | 0.02% | 736 |
|
|
2021
Q1 | $834K | Sell |
15,156
-846
| -5% | -$46.9K | 0.02% | 766 |
|
|
2020
Q4 | $873K | Sell |
16,002
-18,672
| -54% | -$976K | 0.02% | 695 |
|
|
2020
Q3 | $1.73M | Sell |
34,674
-9,432
| -21% | -$457K | 0.04% | 420 |
|
|
2020
Q2 | $1.95M | Sell |
44,106
-5,784
| -12% | -$247K | 0.05% | 391 |
|
|
2020
Q1 | $1.87M | Sell |
49,890
-9,708
| -16% | -$409K | 0.06% | 350 |
|
|
2019
Q4 | $2.63M | Sell |
59,598
-109,476
| -65% | -$4.6M | 0.07% | 335 |
|
|
2019
Q3 | $6.97M | Buy |
169,074
+8,736
| +5% | +$358K | 0.19% | 122 |
|
|
2019
Q2 | $6.43M | Sell |
160,338
-3,858
| -2% | -$146K | 0.17% | 128 |
|
|
2019
Q1 | $6.34M | Buy |
164,196
+29,754
| +22% | +$1.08M | 0.17% | 130 |
|
|
2018
Q4 | $4.48M | Sell |
134,442
-16,968
| -11% | -$588K | 0.14% | 160 |
|
|
2018
Q3 | $5.74M | Buy |
151,410
+38,304
| +34% | +$1.36M | 0.15% | 160 |
|
|
2018
Q2 | $3.78M | Buy |
113,106
+9,504
| +9% | +$310K | 0.1% | 224 |
|
|
2018
Q1 | $3.19M | Buy |
103,602
+594
| +0.6% | +$18.3K | 0.08% | 275 |
|
|
2017
Q4 | $2.98M | Buy |
103,008
+10,176
| +11% | +$293K | 0.08% | 299 |
|
|
2017
Q3 | $2.58M | Sell |
92,832
-2,700
| -3% | -$74.7K | 0.07% | 320 |
|
|
2017
Q2 | $2.65M | Buy |
95,532
+2,784
| +3% | +$73.7K | 0.07% | 327 |
|
|
2017
Q1 | $2.34M | Sell |
92,748
-23,130
| -20% | -$561K | 0.07% | 345 |
|
|
2016
Q4 | $2.57M | Sell |
115,878
-184,362
| -61% | -$4.19M | 0.07% | 311 |
|
|
2016
Q3 | $7.28M | Buy |
300,240
+14,964
| +5% | +$356K | 0.21% | 105 |
|
|
2016
Q2 | $6.45M | Buy |
285,276
+186,330
| +188% | +$4.04M | 0.19% | 113 |
|
|
2016
Q1 | $2.02M | Buy |
98,946
+85,320
| +626% | +$1.66M | 0.06% | 346 |
|
|
2015
Q4 | $278K | Hold |
13,626
| – | – | 0.01% | 984 |
|
|
2015
Q3 | $253K | Buy |
13,626
+108
| +0.8% | +$2.17K | 0.01% | 1060 |
|
|
2015
Q2 | $270K | Sell |
13,518
-10,470
| -44% | -$210K | 0.01% | 1142 |
|
|
2015
Q1 | $481K | Buy |
+23,988
| New | +$468K | 0.01% | 883 |
|
Other funds holding IHI
AAS
Oppenheimer & Co's IHI Position: Q2 2026 in Review
Oppenheimer & Co reduced its iShares US Medical Devices ETF (IHI) stake by 46% in Q2 2026, selling an estimated $326K and leaving 7,521 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #1389.
Oppenheimer & Co first reported a position in IHI in Q1 2015 and has held it in 46 quarters since. The position peaked at $7.28M in Q3 2016. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Oppenheimer & Co held 7,521 shares of iShares US Medical Devices ETF worth $372K as of Q2 2026.
- Oppenheimer & Co sold 6,418 iShares US Medical Devices ETF shares in Q2 2026, an estimated $326K.
- iShares US Medical Devices ETF made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1389 holding.
- Oppenheimer & Co first reported a position in iShares US Medical Devices ETF in Q1 2015 and has held it in 46 quarters since.
- Oppenheimer & Co's iShares US Medical Devices ETF position peaked at $7.28M in Q3 2016.
- 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.